Reports

Industry Research Reports

Home > Reports > Medical Devices & Consumables > Ischemia Reperfusion Injury- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Ischemia Reperfusion Injury- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Ischemia Reperfusion Injury- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-18

Pages: 108 Pages

Report ld: 3437797

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Ischemia Reperfusion Injury was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.

North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.

In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.

This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Ischemia Reperfusion Injury by region & country, by Type, and by Application.

The Ischemia Reperfusion Injury market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury.

MARKET SEGMENTATION

By Company

  • Angion Biomedica
  • Catalyst Biosciences
  • Ischemix Inc
  • Opsona Therapeutics
  • Pharming
  • TheraSource
  • Bolder Biotechnology
  • Corline Biomedical
  • Mifcortx
  • Balmes Transplantation
  • NovelMed Therapeutics
  • Hope Pharmaceuticals
  • Omeros Corp
  • Prothix
  • SBI Pharmaceuticals

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Phase 1
  • Phase 2
  • Preclinical

Segment by Application

  • Heart Injury
  • Kidney Injury
  • Intestine Injury
  • Other Injury

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Ischemia Reperfusion Injury company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Revenue of Ischemia Reperfusion Injury in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Revenue of Ischemia Reperfusion Injury in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Ischemia Reperfusion Injury Product Introduction

1.2 Global Ischemia Reperfusion Injury Market Size Forecast (2020-2031)

1.3 Ischemia Reperfusion Injury Market Trends & Drivers

1.3.1 Ischemia Reperfusion Injury Industry Trends

1.3.2 Ischemia Reperfusion Injury Market Drivers & Opportunity

1.3.3 Ischemia Reperfusion Injury Market Challenges

1.3.4 Ischemia Reperfusion Injury Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Ischemia Reperfusion Injury Players Revenue Ranking (2024)

2.2 Global Ischemia Reperfusion Injury Revenue by Company (2020-2025)

2.3 Key Companies Ischemia Reperfusion Injury Manufacturing Base Distribution and Headquarters

2.4 Key Companies Ischemia Reperfusion Injury Product Offered

2.5 Key Companies Time to Begin Mass Production of Ischemia Reperfusion Injury

2.6 Ischemia Reperfusion Injury Market Competitive Analysis

2.6.1 Ischemia Reperfusion Injury Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Ischemia Reperfusion Injury Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury as of 2024)

2.7 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Phase 1

3.1.2 Phase 2

3.1.3 Preclinical

3.2 Global Ischemia Reperfusion Injury Sales Value by Type

3.2.1 Global Ischemia Reperfusion Injury Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Ischemia Reperfusion Injury Sales Value, by Type (2020-2031)

3.2.3 Global Ischemia Reperfusion Injury Sales Value, by Type (%) (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Heart Injury

4.1.2 Kidney Injury

4.1.3 Intestine Injury

4.1.4 Other Injury

4.2 Global Ischemia Reperfusion Injury Sales Value by Application

4.2.1 Global Ischemia Reperfusion Injury Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Ischemia Reperfusion Injury Sales Value, by Application (2020-2031)

4.2.3 Global Ischemia Reperfusion Injury Sales Value, by Application (%) (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Ischemia Reperfusion Injury Sales Value by Region

5.1.1 Global Ischemia Reperfusion Injury Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Ischemia Reperfusion Injury Sales Value by Region (2020-2025)

5.1.3 Global Ischemia Reperfusion Injury Sales Value by Region (2026-2031)

5.1.4 Global Ischemia Reperfusion Injury Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Ischemia Reperfusion Injury Sales Value, 2020-2031

5.2.2 North America Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Ischemia Reperfusion Injury Sales Value, 2020-2031

5.3.2 Europe Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Ischemia Reperfusion Injury Sales Value, 2020-2031

5.4.2 Asia Pacific Ischemia Reperfusion Injury Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Ischemia Reperfusion Injury Sales Value, 2020-2031

5.5.2 South America Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Ischemia Reperfusion Injury Sales Value, 2020-2031

5.6.2 Middle East & Africa Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Ischemia Reperfusion Injury Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Ischemia Reperfusion Injury Sales Value, 2020-2031

6.3 United States

6.3.1 United States Ischemia Reperfusion Injury Sales Value, 2020-2031

6.3.2 United States Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Ischemia Reperfusion Injury Sales Value, 2020-2031

6.4.2 Europe Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Ischemia Reperfusion Injury Sales Value, 2020-2031

6.5.2 China Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.5.3 China Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Ischemia Reperfusion Injury Sales Value, 2020-2031

6.6.2 Japan Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Ischemia Reperfusion Injury Sales Value, 2020-2031

6.7.2 South Korea Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Ischemia Reperfusion Injury Sales Value, 2020-2031

6.8.2 Southeast Asia Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Ischemia Reperfusion Injury Sales Value, 2020-2031

6.9.2 India Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031

6.9.3 India Ischemia Reperfusion Injury Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 Angion Biomedica

7.1.1 Angion Biomedica Profile

7.1.2 Angion Biomedica Main Business

7.1.3 Angion Biomedica Ischemia Reperfusion Injury Products, Services and Solutions

7.1.4 Angion Biomedica Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.1.5 Angion Biomedica Recent Developments

7.2 Catalyst Biosciences

7.2.1 Catalyst Biosciences Profile

7.2.2 Catalyst Biosciences Main Business

7.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Products, Services and Solutions

7.2.4 Catalyst Biosciences Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.2.5 Catalyst Biosciences Recent Developments

7.3 Ischemix Inc

7.3.1 Ischemix Inc Profile

7.3.2 Ischemix Inc Main Business

7.3.3 Ischemix Inc Ischemia Reperfusion Injury Products, Services and Solutions

7.3.4 Ischemix Inc Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.3.5 Ischemix Inc Recent Developments

7.4 Opsona Therapeutics

7.4.1 Opsona Therapeutics Profile

7.4.2 Opsona Therapeutics Main Business

7.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Products, Services and Solutions

7.4.4 Opsona Therapeutics Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.4.5 Opsona Therapeutics Recent Developments

7.5 Pharming

7.5.1 Pharming Profile

7.5.2 Pharming Main Business

7.5.3 Pharming Ischemia Reperfusion Injury Products, Services and Solutions

7.5.4 Pharming Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.5.5 Pharming Recent Developments

7.6 TheraSource

7.6.1 TheraSource Profile

7.6.2 TheraSource Main Business

7.6.3 TheraSource Ischemia Reperfusion Injury Products, Services and Solutions

7.6.4 TheraSource Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.6.5 TheraSource Recent Developments

7.7 Bolder Biotechnology

7.7.1 Bolder Biotechnology Profile

7.7.2 Bolder Biotechnology Main Business

7.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Products, Services and Solutions

7.7.4 Bolder Biotechnology Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.7.5 Bolder Biotechnology Recent Developments

7.8 Corline Biomedical

7.8.1 Corline Biomedical Profile

7.8.2 Corline Biomedical Main Business

7.8.3 Corline Biomedical Ischemia Reperfusion Injury Products, Services and Solutions

7.8.4 Corline Biomedical Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.8.5 Corline Biomedical Recent Developments

7.9 Mifcortx

7.9.1 Mifcortx Profile

7.9.2 Mifcortx Main Business

7.9.3 Mifcortx Ischemia Reperfusion Injury Products, Services and Solutions

7.9.4 Mifcortx Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.9.5 Mifcortx Recent Developments

7.10 Balmes Transplantation

7.10.1 Balmes Transplantation Profile

7.10.2 Balmes Transplantation Main Business

7.10.3 Balmes Transplantation Ischemia Reperfusion Injury Products, Services and Solutions

7.10.4 Balmes Transplantation Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.10.5 Balmes Transplantation Recent Developments

7.11 NovelMed Therapeutics

7.11.1 NovelMed Therapeutics Profile

7.11.2 NovelMed Therapeutics Main Business

7.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Products, Services and Solutions

7.11.4 NovelMed Therapeutics Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.11.5 NovelMed Therapeutics Recent Developments

7.12 Hope Pharmaceuticals

7.12.1 Hope Pharmaceuticals Profile

7.12.2 Hope Pharmaceuticals Main Business

7.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Products, Services and Solutions

7.12.4 Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.12.5 Hope Pharmaceuticals Recent Developments

7.13 Omeros Corp

7.13.1 Omeros Corp Profile

7.13.2 Omeros Corp Main Business

7.13.3 Omeros Corp Ischemia Reperfusion Injury Products, Services and Solutions

7.13.4 Omeros Corp Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.13.5 Omeros Corp Recent Developments

7.14 Prothix

7.14.1 Prothix Profile

7.14.2 Prothix Main Business

7.14.3 Prothix Ischemia Reperfusion Injury Products, Services and Solutions

7.14.4 Prothix Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.14.5 Prothix Recent Developments

7.15 SBI Pharmaceuticals

7.15.1 SBI Pharmaceuticals Profile

7.15.2 SBI Pharmaceuticals Main Business

7.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Products, Services and Solutions

7.15.4 SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue (US$ Million) & (2020-2025)

7.15.5 SBI Pharmaceuticals Recent Developments

muLu

8 Industry Chain Analysis

8.1 Ischemia Reperfusion Injury Industrial Chain

8.2 Ischemia Reperfusion Injury Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Ischemia Reperfusion Injury Sales Model

8.5.2 Sales Channel

8.5.3 Ischemia Reperfusion Injury Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Ischemia Reperfusion Injury Market Trends
Table 2. Ischemia Reperfusion Injury Market Drivers & Opportunity
Table 3. Ischemia Reperfusion Injury Market Challenges
Table 4. Ischemia Reperfusion Injury Market Restraints
Table 5. Global Ischemia Reperfusion Injury Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Ischemia Reperfusion Injury Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Ischemia Reperfusion Injury Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Ischemia Reperfusion Injury Product Type
Table 9. Key Companies Time to Begin Mass Production of Ischemia Reperfusion Injury
Table 10. Global Ischemia Reperfusion Injury Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Ischemia Reperfusion Injury Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Ischemia Reperfusion Injury Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Ischemia Reperfusion Injury Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Ischemia Reperfusion Injury Sales Market Share in Value by Type (2020-2025)
Table 17. Global Ischemia Reperfusion Injury Sales Market Share in Value by Type (2026-2031)
Table 18. Global Ischemia Reperfusion Injury Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Ischemia Reperfusion Injury Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Ischemia Reperfusion Injury Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Ischemia Reperfusion Injury Sales Market Share in Value by Application (2020-2025)
Table 22. Global Ischemia Reperfusion Injury Sales Market Share in Value by Application (2026-2031)
Table 23. Global Ischemia Reperfusion Injury Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Ischemia Reperfusion Injury Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Ischemia Reperfusion Injury Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Ischemia Reperfusion Injury Sales Value by Region (2020-2025) & (%)
Table 27. Global Ischemia Reperfusion Injury Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Ischemia Reperfusion Injury Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Ischemia Reperfusion Injury Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Ischemia Reperfusion Injury Sales Value, (2026-2031) & (US$ Million)
Table 31. Angion Biomedica Basic Information List
Table 32. Angion Biomedica Description and Business Overview
Table 33. Angion Biomedica Ischemia Reperfusion Injury Products, Services and Solutions
Table 34. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Angion Biomedica (2020-2025)
Table 35. Angion Biomedica Recent Developments
Table 36. Catalyst Biosciences Basic Information List
Table 37. Catalyst Biosciences Description and Business Overview
Table 38. Catalyst Biosciences Ischemia Reperfusion Injury Products, Services and Solutions
Table 39. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Catalyst Biosciences (2020-2025)
Table 40. Catalyst Biosciences Recent Developments
Table 41. Ischemix Inc Basic Information List
Table 42. Ischemix Inc Description and Business Overview
Table 43. Ischemix Inc Ischemia Reperfusion Injury Products, Services and Solutions
Table 44. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Ischemix Inc (2020-2025)
Table 45. Ischemix Inc Recent Developments
Table 46. Opsona Therapeutics Basic Information List
Table 47. Opsona Therapeutics Description and Business Overview
Table 48. Opsona Therapeutics Ischemia Reperfusion Injury Products, Services and Solutions
Table 49. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Opsona Therapeutics (2020-2025)
Table 50. Opsona Therapeutics Recent Developments
Table 51. Pharming Basic Information List
Table 52. Pharming Description and Business Overview
Table 53. Pharming Ischemia Reperfusion Injury Products, Services and Solutions
Table 54. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Pharming (2020-2025)
Table 55. Pharming Recent Developments
Table 56. TheraSource Basic Information List
Table 57. TheraSource Description and Business Overview
Table 58. TheraSource Ischemia Reperfusion Injury Products, Services and Solutions
Table 59. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of TheraSource (2020-2025)
Table 60. TheraSource Recent Developments
Table 61. Bolder Biotechnology Basic Information List
Table 62. Bolder Biotechnology Description and Business Overview
Table 63. Bolder Biotechnology Ischemia Reperfusion Injury Products, Services and Solutions
Table 64. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Bolder Biotechnology (2020-2025)
Table 65. Bolder Biotechnology Recent Developments
Table 66. Corline Biomedical Basic Information List
Table 67. Corline Biomedical Description and Business Overview
Table 68. Corline Biomedical Ischemia Reperfusion Injury Products, Services and Solutions
Table 69. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Corline Biomedical (2020-2025)
Table 70. Corline Biomedical Recent Developments
Table 71. Mifcortx Basic Information List
Table 72. Mifcortx Description and Business Overview
Table 73. Mifcortx Ischemia Reperfusion Injury Products, Services and Solutions
Table 74. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Mifcortx (2020-2025)
Table 75. Mifcortx Recent Developments
Table 76. Balmes Transplantation Basic Information List
Table 77. Balmes Transplantation Description and Business Overview
Table 78. Balmes Transplantation Ischemia Reperfusion Injury Products, Services and Solutions
Table 79. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Balmes Transplantation (2020-2025)
Table 80. Balmes Transplantation Recent Developments
Table 81. NovelMed Therapeutics Basic Information List
Table 82. NovelMed Therapeutics Description and Business Overview
Table 83. NovelMed Therapeutics Ischemia Reperfusion Injury Products, Services and Solutions
Table 84. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of NovelMed Therapeutics (2020-2025)
Table 85. NovelMed Therapeutics Recent Developments
Table 86. Hope Pharmaceuticals Basic Information List
Table 87. Hope Pharmaceuticals Description and Business Overview
Table 88. Hope Pharmaceuticals Ischemia Reperfusion Injury Products, Services and Solutions
Table 89. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Hope Pharmaceuticals (2020-2025)
Table 90. Hope Pharmaceuticals Recent Developments
Table 91. Omeros Corp Basic Information List
Table 92. Omeros Corp Description and Business Overview
Table 93. Omeros Corp Ischemia Reperfusion Injury Products, Services and Solutions
Table 94. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Omeros Corp (2020-2025)
Table 95. Omeros Corp Recent Developments
Table 96. Prothix Basic Information List
Table 97. Prothix Description and Business Overview
Table 98. Prothix Ischemia Reperfusion Injury Products, Services and Solutions
Table 99. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of Prothix (2020-2025)
Table 100. Prothix Recent Developments
Table 101. SBI Pharmaceuticals Basic Information List
Table 102. SBI Pharmaceuticals Description and Business Overview
Table 103. SBI Pharmaceuticals Ischemia Reperfusion Injury Products, Services and Solutions
Table 104. Revenue (US$ Million) in Ischemia Reperfusion Injury Business of SBI Pharmaceuticals (2020-2025)
Table 105. SBI Pharmaceuticals Recent Developments
Table 106. Key Raw Materials Lists
Table 107. Raw Materials Key Suppliers Lists
Table 108. Ischemia Reperfusion Injury Downstream Customers
Table 109. Ischemia Reperfusion Injury Distributors List
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Business Unit and Senior & Team Lead Analysts
muLu

List of Figures

Figure 1. Ischemia Reperfusion Injury Product Picture
Figure 2. Global Ischemia Reperfusion Injury Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Ischemia Reperfusion Injury Sales Value (2020-2031) & (US$ Million)
Figure 4. Ischemia Reperfusion Injury Report Years Considered
Figure 5. Global Ischemia Reperfusion Injury Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Ischemia Reperfusion Injury Revenue in 2024
Figure 7. Ischemia Reperfusion Injury Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Phase 1 Picture
Figure 9. Phase 2 Picture
Figure 10. Preclinical Picture
Figure 11. Global Ischemia Reperfusion Injury Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Ischemia Reperfusion Injury Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Heart Injury
Figure 14. Product Picture of Kidney Injury
Figure 15. Product Picture of Intestine Injury
Figure 16. Product Picture of Other Injury
Figure 17. Global Ischemia Reperfusion Injury Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global Ischemia Reperfusion Injury Sales Value Market Share by Application, 2024 & 2031
Figure 19. North America Ischemia Reperfusion Injury Sales Value (2020-2031) & (US$ Million)
Figure 20. North America Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031
Figure 21. Europe Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 22. Europe Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031
Figure 23. Asia Pacific Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 24. Asia Pacific Ischemia Reperfusion Injury Sales Value by Region (%), 2024 VS 2031
Figure 25. South America Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 26. South America Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031
Figure 27. Middle East & Africa Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 28. Middle East & Africa Ischemia Reperfusion Injury Sales Value by Country (%), 2024 VS 2031
Figure 29. Key Countries/Regions Ischemia Reperfusion Injury Sales Value (%), (2020-2031)
Figure 30. United States Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 31. United States Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 32. United States Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 33. Europe Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 35. Europe Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 36. China Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 37. China Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 38. China Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 39. Japan Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 40. Japan Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 41. Japan Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 42. South Korea Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 43. South Korea Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 44. South Korea Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 45. Southeast Asia Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 47. Southeast Asia Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 48. India Ischemia Reperfusion Injury Sales Value, (2020-2031) & (US$ Million)
Figure 49. India Ischemia Reperfusion Injury Sales Value by Type (%), 2024 VS 2031
Figure 50. India Ischemia Reperfusion Injury Sales Value by Application (%), 2024 VS 2031
Figure 51. Ischemia Reperfusion Injury Industrial Chain
Figure 52. Ischemia Reperfusion Injury Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Ischemia Reperfusion Injury market?zhanKai
The top companies in the global Ischemia Reperfusion Injury market are Angion Biomedica、Catalyst Biosciences、Ischemix Inc.
den_biaoTiZhungShi

Related Reports

Ischemia Reperfusion Injury- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-18

Pages: 108 Pages

Report ld: 3437797

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Offline

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Offline

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Offline

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now